Neurocrine Biosciences マネジメント
マネジメント 基準チェック /44
Neurocrine Biosciencesの CEO はKyle Ganoで、 Jan2011年に任命され、 の在任期間は 13.83年です。 の年間総報酬は$ 5.99Mで、 10.1%給与と89.9%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.13%を直接所有しており、その価値は$ 16.69M 。経営陣と取締役会の平均在任期間はそれぞれ6.9年と9.1年です。
主要情報
Kyle Gano
最高経営責任者
US$6.0m
報酬総額
CEO給与比率 | 10.1% |
CEO在任期間 | 13.8yrs |
CEOの所有権 | 0.1% |
経営陣の平均在職期間 | 6.9yrs |
取締役会の平均在任期間 | 9.1yrs |
経営陣の近況
Recent updates
Neurocrine: A Buy Amid CNS Pipeline Growth And Ingrezza's Strength (Rating Upgrade)
Oct 10The Play On Neurocrine Biosciences
Oct 02Neurocrine: Buying Opportunity After Stock Price Drop On Schizophrenia Data
Aug 28Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly
Jul 28Neurocrine's Pipeline, Including Crinecerfont's Priority Review, Drives Long-Term Growth
Jul 09Shareholders Can Be Confident That Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are High Quality
May 08Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings
Apr 27Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data
Apr 25Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly
Mar 31Neurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional Upside
Feb 11Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings
Jan 07Neurocrine Biosciences (NASDAQ:NBIX) Could Easily Take On More Debt
Dec 11Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?
Sep 12We Think Neurocrine Biosciences (NASDAQ:NBIX) Can Manage Its Debt With Ease
Jun 08CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$386m |
Jun 30 2024 | n/a | n/a | US$339m |
Mar 31 2024 | n/a | n/a | US$370m |
Dec 31 2023 | US$6m | US$603k | US$250m |
Sep 30 2023 | n/a | n/a | US$191m |
Jun 30 2023 | n/a | n/a | US$176m |
Mar 31 2023 | n/a | n/a | US$64m |
Dec 31 2022 | US$5m | US$551k | US$155m |
Sep 30 2022 | n/a | n/a | US$58m |
Jun 30 2022 | n/a | n/a | US$12m |
Mar 31 2022 | n/a | n/a | US$71m |
Dec 31 2021 | US$6m | US$517k | US$90m |
Sep 30 2021 | n/a | n/a | US$445m |
Jun 30 2021 | n/a | n/a | US$365m |
Mar 31 2021 | n/a | n/a | US$402m |
Dec 31 2020 | US$7m | US$488k | US$407m |
Sep 30 2020 | n/a | n/a | US$93m |
Jun 30 2020 | n/a | n/a | US$205m |
Mar 31 2020 | n/a | n/a | US$177m |
Dec 31 2019 | US$5m | US$443k | US$37m |
Sep 30 2019 | n/a | n/a | US$21m |
Jun 30 2019 | n/a | n/a | US$18m |
Mar 31 2019 | n/a | n/a | -US$39m |
Dec 31 2018 | US$5m | US$403k | US$21m |
Sep 30 2018 | n/a | n/a | US$10m |
Jun 30 2018 | n/a | n/a | -US$52m |
Mar 31 2018 | n/a | n/a | -US$106m |
Dec 31 2017 | US$2m | US$375k | -US$143m |
報酬と市場: Kyleの 総報酬 ($USD 5.99M ) は、 US市場 ($USD 12.73M ) の同様の規模の企業の平均を下回っています。
報酬と収益: Kyleの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Kyle Gano (51 yo)
13.8yrs
在職期間
US$5,990,215
報酬
Mr. Kyle W. Gano, Ph D., is CEO and Director at Neurocrine Biosciences, Inc since October 11, 2024. He was Chief Business Development and Strategy Officer at Neurocrine Biosciences, Inc. since 2020 until O...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
CEO & Director | 13.8yrs | US$5.99m | 0.13% $ 16.7m | |
Chief Financial Officer | 7yrs | US$6.06m | 0.031% $ 3.9m | |
Chief Scientific Officer | 3yrs | US$7.22m | 0.013% $ 1.6m | |
Chief Medical Officer | 6.8yrs | US$5.87m | 0.031% $ 3.8m | |
Head of Investor Relations | no data | データなし | データなし | |
Chief Legal Officer & Corporate Secretary | 10.1yrs | US$4.72m | 0.039% $ 4.9m | |
Chief Human Resources Officer | 7.2yrs | データなし | 0.018% $ 2.2m | |
Chief Commercial Officer | 9.5yrs | US$5.81m | 0.040% $ 5.0m | |
Chief Corporate Affairs Officer | 5.2yrs | データなし | 0.00037% $ 46.2k | |
Chief Regulatory Officer | 2.1yrs | データなし | 0.0025% $ 309.6k | |
Exclusive Consultant | 6.8yrs | US$3.10m | データなし |
6.9yrs
平均在職期間
58yo
平均年齢
経験豊富な経営陣: NBIXの経営陣は経験豊富で経験豊富です(平均在職期間は6.9年)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
CEO & Director | less than a year | US$5.99m | 0.13% $ 16.7m | |
Independent Director | 1.3yrs | US$813.45k | 0% $ 0 | |
Independent Director | 26.6yrs | US$492.04k | 0.031% $ 3.9m | |
Independent Director | 25.6yrs | US$479.54k | 0.024% $ 3.0m | |
Independent Chairman of the Board | 14.8yrs | US$495.04k | 0.037% $ 4.6m | |
Independent Director | 31.8yrs | US$460.11k | 0.12% $ 14.7m | |
Independent Director | 9.1yrs | US$479.54k | 0.0042% $ 518.0k | |
Director | 16.8yrs | US$15.75m | 0.51% $ 63.4m | |
Independent Director | 4.8yrs | US$497.11k | 0.00098% $ 122.3k | |
Independent Director | 5.2yrs | US$475.11k | 0.00098% $ 122.3k | |
Independent Director | 3.6yrs | US$467.61k | 0.0021% $ 258.4k |
9.1yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: NBIXの 取締役会 は 経験豊富 であると考えられます ( 9.1年の平均在任期間)。